MeSH term
Frequency | Condition_Probility | Humans | 58 | 0.0 |
Blood Proteins/pharmacology | 2 | 4.0 |
Calcium/*metabolism | 15 | 2.0 |
Calcium Channels/*genetics/*metabolism | 2 | 22.0 |
Cell Division/drug effects/physiology | 2 | 0.0 |
Cells, Cultured | 8 | 0.0 |
Gene Expression/physiology | 2 | 0.0 |
Membrane Potentials/drug effects/physiology | 2 | 2.0 |
Nickel/pharmacology | 2 | 8.0 |
RNA, Messenger/metabolism | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 37 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 14 | 0.0 |
Mutation | 3 | 0.0 |
Plasmids | 5 | 0.0 |
Saccharomyces cerevisiae/*genetics | 4 | 2.0 |
Transformation, Genetic | 2 | 1.0 |
Animals | 26 | 0.0 |
Hamsters | 2 | 0.0 |
Hybrid Cells | 2 | 0.0 |
Transfection | 10 | 0.0 |
Amino Acid Sequence | 14 | 0.0 |
Binding Sites | 2 | 0.0 |
Cattle | 3 | 0.0 |
Molecular Sequence Data | 16 | 0.0 |
Sequence Alignment | 9 | 0.0 |
Biological Transport | 2 | 0.0 |
Blood Platelets/*metabolism | 4 | 1.0 |
Blotting, Western | 5 | 0.0 |
Calcium Channel Blockers/pharmacology | 2 | 2.0 |
Thapsigargin/pharmacology | 8 | 7.0 |
Thrombin/pharmacology | 2 | 0.0 |
Adult | 4 | 0.0 |
Female | 6 | 0.0 |
Genotype | 2 | 0.0 |
Male | 7 | 0.0 |
*Membrane Glycoproteins | 9 | 1.0 |
Middle Aged | 4 | 0.0 |
*Oxidoreductases | 9 | 11.0 |
T-Lymphocytes/*immunology | 2 | 0.0 |
Base Sequence | 10 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 5 | 0.0 |
Tumor Cells, Cultured | 6 | 0.0 |
Calcium Channels/genetics/*metabolism | 3 | 15.0 |
In Vitro | 2 | 0.0 |
Sequence Analysis, DNA | 2 | 0.0 |
Calcium/metabolism | 4 | 0.0 |
Comparative Study | 6 | 0.0 |
Patch-Clamp Techniques | 2 | 0.0 |
Calcium Channels/*metabolism | 4 | 8.0 |
Receptors, Cytoplasmic and Nuclear/metabolism | 4 | 3.0 |
Enzyme Inhibitors/pharmacology | 2 | 0.0 |
Protein Binding | 2 | 0.0 |
Receptors, Cytoplasmic and Nuclear/*metabolism | 2 | 1.0 |
Aged | 3 | 0.0 |
Aged, 80 and over | 2 | 0.0 |
Time Factors | 2 | 0.0 |
Drosophila | 3 | 0.0 |
Kinetics | 3 | 0.0 |
Mammals | 2 | 0.0 |
Mice | 13 | 0.0 |
Sequence Homology, Amino Acid | 5 | 0.0 |
RNA, Messenger/analysis | 2 | 0.0 |
Gene Expression | 2 | 0.0 |
Rats | 5 | 0.0 |
Melanoma/*immunology | 2 | 2.0 |
Melanocytes/metabolism | 2 | 5.0 |
Proteins/metabolism | 3 | 0.0 |
Carbachol/pharmacology | 3 | 3.0 |
Structure-Activity Relationship | 3 | 0.0 |
Glycosylation | 3 | 0.0 |
Monophenol Monooxygenase/metabolism | 3 | 15.0 |
Calcium Channels/genetics/*physiology | 2 | 18.0 |
Cell Line | 5 | 0.0 |
Recombinant Proteins/metabolism | 2 | 0.0 |
Protein Conformation | 3 | 0.0 |
Ion Transport | 2 | 2.0 |
Cloning, Molecular | 8 | 0.0 |
*Drosophila Proteins | 2 | 0.0 |
Gene Library | 3 | 0.0 |
Hela Cells | 2 | 0.0 |
Immunohistochemistry | 4 | 0.0 |
Recombinant Proteins/biosynthesis/chemistry | 2 | 2.0 |
Transcription, Genetic | 3 | 0.0 |
Calcium Channels/*physiology | 2 | 8.0 |
Genetic Vectors | 2 | 0.0 |
COS Cells | 2 | 0.0 |
Melanins/biosynthesis | 2 | 10.0 |
*Intramolecular Oxidoreductases | 4 | 25.0 |
Isomerases/metabolism | 2 | 25.0 |
Proteins/*metabolism | 2 | 0.0 |
DNA Primers | 2 | 0.0 |
Polymerase Chain Reaction | 2 | 0.0 |
Melanins/*biosynthesis | 2 | 12.0 |
Phenotype | 3 | 0.0 |
Species Specificity | 2 | 0.0 |
Phylogeny | 2 | 0.0 |
Chromosome Mapping | 2 | 0.0 |
Nucleic Acid Hybridization | 2 | 0.0 |
Restriction Mapping | 2 | 0.0 |
*Genes, Structural | 2 | 0.0 |
Promoter Regions (Genetics) | 2 | 0.0 |
Gene Expression Regulation | 2 | 0.0 |
